Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.
about
Device-based Therapy for HypertensionNon-pharmacological modulation of the autonomic tone to treat heart failureCarotid Baroreceptor Stimulation and Arteriovenous Shunts for Resistant HypertensionBaroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective.Treatment resistant hypertension--investigation and conservative managementTissue damage thresholds during therapeutic electrical stimulationChronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease.The baroreflex as a long-term controller of arterial pressure.Surgical, interventional, and device innovations in the management of hypertensionBaroreflex activation: from mechanisms to therapy for cardiovascular disease.Global- and renal-specific sympathoinhibition in aldosterone hypertensionIntermittent electrical stimulation of the right cervical vagus nerve in salt-sensitive hypertensive rats: effects on blood pressure, arrhythmias, and ventricular electrophysiology.Open-loop static and dynamic characteristics of the arterial baroreflex system in rabbits and rats.Acute arterial baroreflex-mediated changes in plasma catecholamine concentrations in a chronic rat model of myocardial infarction.Management of patients with resistant hypertension: current treatment options.Timing and efficacy of alternative methods of sympathetic blockade.Interventional treatment of hypertension: a new paradigm.Resistant hypertension: patient characteristics, risk factors, co-morbidities and outcomes.Baroreflex activation therapy in hypertension.The baroreceptor as a therapeutic target for heart failure.The role of nonpharmacologic device interventions in the management of drug-resistant hypertension.Novel and nonpharmacologic approaches to cardio-protection in hypertension.Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease.Baroreflex activation therapy for patients with drug-resistant hypertension.Invasive treatment of resistant hypertension: present and future.Carotid baroreceptor stimulation: a potential solution for resistant hypertensionDeep brain stimulation for the treatment of resistant hypertension.Where and when device therapy may be useful in the management of drug-resistant hypertension.Renal Denervation in Heart Failure.Drug therapy for the patient with resistant hypertension.Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure.Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity?The Role of Central Nervous System Mechanisms in Resistant Hypertension.Carotid baroreflex activation therapy for resistant hypertension.Electrical carotid sinus stimulation: chances and challenges in the management of treatment resistant arterial hypertension.Present and Future of Interventional Treatment of Resistant Hypertension.Sympathetic Activation in Chronic Heart Failure: Potential Benefits of Interventional Therapies.Interventional procedures and future drug therapy for hypertension.Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights.
P2860
Q26745518-57848289-1FD8-4CD8-82B6-2108F9E1021FQ26822899-DAFF7A1D-EE86-4FF4-8F22-F36C86D91A43Q28067497-B09EB072-F57F-43C0-9896-0F3121725D27Q31046062-048C7CA1-8A6B-4C7B-B5C6-3E7A9EC9BBAEQ33892370-8F352B33-7DFF-44B1-8736-650F9F9B1D8AQ34510131-E1B3C89D-EE68-4361-9E8B-D2F44EA24537Q34543021-1795A564-FF60-40ED-85D9-A0C76000876DQ34972079-4F83857C-E912-454D-AF23-0BD550EE7380Q35138352-9006F909-1F2C-4CE2-A1AD-30A31F060FCEQ35141548-065FC8CD-19B1-4866-B764-C896F0303062Q35190670-FA3EC5D4-1182-4FC4-B889-43E0C78FF437Q35611525-7009FD25-1902-44C4-9B78-4E75854C0D7DQ36036399-69EAEE9B-894B-4EC0-A7C2-3305B76E3B23Q36547730-9D495955-AF15-46D4-9107-4EE698F20ADDQ37176724-1CC3E801-AC04-4718-A24B-14A3CDECDC44Q37304418-250B82E4-FA57-4B7F-9D05-A00083E800AFQ38029565-035BD6C9-9D58-4F3A-AB35-C28D00BE4D01Q38092756-878FD3B6-0AE3-4CF8-AFF5-6539D9F0C04BQ38132337-0641A05A-45D6-4562-9765-A70679093ADDQ38183248-E4D5F1F2-7C89-4A1F-AE05-C073E86CD948Q38190492-9028B69E-9A2F-4833-896B-7CABDF7158E5Q38195525-311617A1-F821-4E73-B8A9-551FF7C2675EQ38196355-8217E9A9-8DD1-4526-B8FD-891382D575A6Q38208753-83483088-25D9-4DD5-AD5C-D022AA1ED249Q38228854-9C66274C-5ED1-4009-BA23-51C8BB8AC5C4Q38245560-13620C49-54BD-4CFE-967D-059D36B2DE71Q38246015-0664ABE1-61BE-42EC-80E5-0705DEEA2EB3Q38252533-4FC8167B-66A2-45A8-84B6-CF9E1DFBAB91Q38261168-46C54380-D93D-4D86-9798-577E9D5E9970Q38371168-28E47944-7C01-4452-AABA-6CF04A99A34AQ38373858-5043401B-07F4-4620-8304-1B46B79825C9Q38392598-44B9F7FE-F68B-4207-A69E-8856D46DF86EQ38484107-1C523FE5-3E9F-4D0A-B953-4D1479DA6978Q38526496-D745870F-95B4-4B24-8277-736861FB4446Q38543355-D065E240-436B-4EE7-A464-1AC61C6D5789Q38553738-F4B28D3B-8810-4B24-983E-0752F9FFBE22Q38768579-703027C9-8F09-4EFE-ADB9-A5B50D844262Q38837789-EB4BABAB-8E5A-46A1-A0C2-3DC38EE1EA8FQ38842624-70A5A229-481D-4B37-9280-898FC5228451Q38849638-575D3170-2585-4EC8-BEBE-6A6356CB2CEF
P2860
Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Baroreflex activation therapy ...... up in the Rheos Pivotal Trial.
@ast
Baroreflex activation therapy ...... up in the Rheos Pivotal Trial.
@en
Baroreflex activation therapy ...... up in the Rheos Pivotal Trial.
@nl
type
label
Baroreflex activation therapy ...... up in the Rheos Pivotal Trial.
@ast
Baroreflex activation therapy ...... up in the Rheos Pivotal Trial.
@en
Baroreflex activation therapy ...... up in the Rheos Pivotal Trial.
@nl
prefLabel
Baroreflex activation therapy ...... up in the Rheos Pivotal Trial.
@ast
Baroreflex activation therapy ...... up in the Rheos Pivotal Trial.
@en
Baroreflex activation therapy ...... up in the Rheos Pivotal Trial.
@nl
P2093
P1476
Baroreflex activation therapy ...... up in the Rheos Pivotal Trial.
@en
P2093
Eric G Lovett
George L Bakris
Jill E Schafer
John D Bisognano
Mitra K Nadim
P304
P356
10.1016/J.JASH.2012.01.003
P577
2012-02-15T00:00:00Z